Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-α

Experimental Hematology

Volumn 27, Issue 7, 1999, Pages 1176-1184

  Wang, Chun ^a   Al Omar, Hamad M ^b   Radvanyi, Laszlo ^a   Banerjee, Avik ^a   Bouman, Derek ^c   Squire, Jeremy ^c   Messner, Hans A ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chronic myeloid leukemia; Dendritic cell; Interferon

Indexed keywords

ALPHA INTERFERON; CD1 ANTIGEN; CD14 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW HYPOPLASIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DENDRITIC CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; BONE MARROW; BONE MARROW CELLS; CELL DIFFERENTIATION; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA ANTIGENS; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON-ALPHA; INTERLEUKIN-4; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LYMPHOCYTE CULTURE TEST, MIXED; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033058936     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00055-7     Document Type: Article

References (27)

1. Hale G., Waldmann H. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases [see comments]. Bone Marrow Transplant. 13:1994;597.
2. Kolb H.J., Schattenberg A., Goldman J.M., Hertenstein B., Jacobsen N., Arcese W., Ljungman P., Ferrant A., Verdonck L., Niederwieser D.et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]. Blood. 86:1995;2041.
3. Mackinnon S., Papadopoulos E.B., Carabasi M.H., Reich L., Collins N.H., Boulad F., Castro-Malaspina H., Childs B.H., Gillio A.P., Kernan N.A.et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation. separation of graft-versus-leukemia responses from graft-versus-host disease Blood. 86:1995;1261.
4. Yee C., Riddell S.R., Greenberg P.D. Prospects for adoptive T cell therapy. Curr Opin Immunol. 9:1997;702.
5. Choudhury A., Gajewski J.L., Liang J.C., Popat U., Claxton D.F., Kliche K.O., Andreeff M., Champlin R.E. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood. 89:1997;1133.
6. + T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia. Blood. 91:1998;977.
7. Eibl B., Ebner S., Duba C., Bock G., Romani N., Erdel M., Gachter A., Niederwieser D., Schuler G. Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Genes Chromosomes Cancer. 20:1997;215.
8. + T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates. Blood. 90:1997;290.
9. Herberman R.B. Effect of alpha-interferons on immune function. Semin Oncol. 24(S9):1997;78.
10. de Waal Malefyt R. The role of type I interferons in the differentiation and function of Th1 and Th2 cells. Semin Oncol. 24(S9):1997;94.
11. Tsukada N., Aoki S., Maruyama S., Kishi K., Takahashi M., Aizawa Y. The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon. J Exp Clin Cancer Res. 16:1997;171.
12. Goldman J.M. Chronic myeloid leukemia. Curr Opin Hematol. 4:1997;277.
13. Guilhot F., Chastang C., Michallet M., Guerci A., Harousseau J.L., Maloisel F., Bouabdallah R., Guyotat D., Cheron N., Nicolini F., Abgrall J.F., Tanzer J. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group [see comments]. N Engl J Med. 337:1997;223.
14. Coulombel L., Kalousek D.K., Eaves C.J., Gupta C.M., Eaves A.C. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N Engl J Med. 308:1983;1493.
15. Frassoni F., Podesta M., Piaggio G., Rosti V., Pitto A., Figari O., Soracco M., Bergamaschi G., Gualandi F., Lamparelli T., Berisso G. Interferon-α protects Philadelphia-negative hematopoietic progenitors from exhaustion in chronic myeloid leukemia (CML) patients with cytogenetic response. Blood. 92(Suppl 1):1998;250a. [abstr].
16. Hart D.N. Dendritic cells. unique leukocyte populations which control the primary immune response Blood. 90:1997;3245.
17. Barch M.J., Knutsen T., Spurbeck J.L. The AGT Cytogenetics Laboratory Manual. 3rd edition:1997;Lippincott-Raven Publishers, New York.
18. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha [published erratum appears in J Exp Med (1996) 183(3):1283]. J Exp Med. 182:1995;1111.
19. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol. 154:1995;5851.
20. Lardon F., Snoeck H.W., Berneman Z.N., Van Tendeloo V.F., Nijs G., Lenjou M., Henckaerts E., Boeckxtaens C.J., Vandenabeele P., Kestens L.L., Van Bockstaele D.R., Vanham G.L. Generation of dendritic cells from bone marrow progenitors using GM- CSF, TNF-alpha, and additional cytokines. antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1 Immunology. 91:1997;553.
21. + hematopoietic progenitor cells. Blood. 87:1996;1292.
22. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258.
23. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med. 184:1996;695.
24. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J Exp Med. 180:1994;83.
25. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 179:1994;1109.
26. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods. 196:1996;137.
27. Smit W.M., Rijnbeek M., van Bergen C.A., de Paus R.A., Vervenne H.A., van de Keur M., Willemze R., Falkenburg J.H. Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum Immunol. 53:1997;216.